From the Department of Obstetrics and Gynecology, the
§ Division of Cardiovascular Biology, Hirschsprung's disease (HSCR) is a congenital
intestinal disease, characterized by the absence of ganglion cells in
the distal portion of the intestinal tract. Recently, three
susceptibility genes have been identified in HSCR, namely the
RET protooncogene, the endothelin B (ETB)
receptor gene (EDNRB), and the endothelin-3 (ET-3) gene
(EDN3). To investigate whether mutations in
EDNRB could be related with HSCR in non-inbred populations
in Japan, we examined alterations of the gene in 31 isolated patients.
Three novel mutations were detected as follows: two transversions, A to
T and C to A at nucleotides 311 (N104I) and 1170 (S390R), respectively, and a transition, T to C at nucleotide 325 (C109R). To analyze functions of these mutant receptors, they were expressed in Chinese hamster ovary cells. S390R mutation did not change the binding affinities but caused the decreases in the ligand-induced increment of
intracellular calcium and in the inhibition of adenylyl cyclase activity, showing the impairment of the intracellular signaling. C109R
receptors were proved to be localized near the nuclei as an unusual
44-kDa protein with the extremely low affinity to endothelin-1 (ET-1)
and not to be translocated into the plasma membrane. On the other hand,
N104I receptors showed almost the same binding affinities and
functional properties as those of the wild type. Therefore, we conclude
that S390R and C109R mutations could cause HSCR but that N104I mutation
might be polymorphous.
Hirschsprung's disease
(HSCR)1 is a congenital
intestinal disorder, characterized by the absence of ganglion cells in
the distal portion of the intestinal tract, as a consequence of
premature arrest of cranio-caudal migration of neural crest cells.
Recently, three susceptibility genes have been identified in HSCR,
namely the RET protooncogene, the endothelin B
(ETB) receptor gene (EDNRB), and the
endothelin-3 (ET-3) gene (EDN3).
Mice with targeted null disruption of Ret exhibited an
autosomal recessive phenotype comprising the total lack of the enteric nervous system and renal agenesis (1), that provided an excellent model
of HSCR. Approximately 50 mutations in RET have so far been identified, and the RET mutations account for 50% of
familial and 15-20% of sporadic cases of HSCR, over 75% of which are
associated with long segment HSCR (2-6).
Endothelins (ETs) are a family of 21 amino acid vasoactive peptides,
consisting of three isopeptides, ET-1, ET-2 and ET-3, that act on G
protein-coupled receptors, ETA and ETB (7-11).
ETA exhibits different affinities to the three isopeptides
in the order of ET-1 Materials--
LipofectAMINE and Trizol were from Life
Technologies, Inc. (Tokyo, Japan). ET-1 and ET-3 were from Peptide
Institute (Osaka, Japan). 125I-NaI was from ICN
Biomedicals, Inc. (Costa Mesa, CA), and fluorescein isothiocyanate-conjugated goat anti-rabbit F(ab')2 was from
ICN Pharmaceuticals, Inc. (Costa Mesa, CA). cAMP radioimmunoassay kit
was from Yamasa (Chiba, Japan). Fura-2/AM was from Dojin Chemicals Institute Co. (Kumamoto, Japan). Platelet activating factor, Geneticin, forskolin, (p-amidinophenyl)methanesulfonyl fluoride,
peroxidase-conjugated goat anti-rabbit IgG, and
3-isobutyl-1-methylxanthine were from Wako Chemicals (Osaka). Sequenase
7-deaza-dGTP DNA sequencing kit was from U. S. Biochemical Corp.
Western blot chemiluminescence reagent was from NEN Life Science
Products.
SSCP and DNA Sequence Analyses--
Oligonucleotide primers
corresponding to each exon of EDNRB were designed according
to the sequences of the intron-exon junctions (25), as follows:
(forward/reverse, 5'-3') exon 1-1,
TTGTCTCTAGGCTCTGAAAC/TTAGTGGGTGGCTCATTAT (213 bp); exon 1-2,
TCCGCTTTTGCAAACCGCAGA/GGACACAACCGTGTTGATGTA (214 bp); exon 1-3,
ATCGAGATCAAGGAGACTTT/CCCTTTACCTTGTAGACATT (212 bp); exon 2, TCAATGCAGCTGCTGGCAGA/AAGCTTCTACCTGTCAATACTC (132 bp); exon 3, TATCTTCAGATATCGAGCTGT/GAAATTTACCTGCATGAAAGC (223 bp); exon 4, ATCCCTATAGTTTTACAAGACAGC/ATTTTCTTACCTGCTTTAGGTG (170 bp); exon 5, TTTATTTCAGAGACGGGAAGT/CCTTTCTTACCTCAAAAGTTC (154 bp); exon 6, TTTGTTGCAGCTTTCTGTTG/AGTCTCTTACCTTAAAGCAG (129 bp); exon 7, TTGTACAGTCATGCTTATGC/TGTTTTAATGACTTCGGTCC (201 bp). The genomic DNAs
were isolated from whole blood by a phenol/chloroform extraction
protocol described elsewhere (26). One-µl aliquots of the PCR
products were mixed with 23 µl of a loading solution containing 96%
deionized formamide, 20 mM EDTA, 0.05% xylene cyanol, and
bromphenol blue. After denaturation at 80 °C for 10 min, 20 µl
were applied to a 15% polyacrylamide gel containing 25 mM
Tris and 192 mM glycine. Electrophoresis was performed at
4 °C for 5-8 h at 400 V with a 25 mM Tris, 192 mM glycine buffer, followed by silver staining. Agarose
gel-purified PCR products were subcloned into M13 vector (26). The
sequence was determined with Sequenase 7-deaza-dGTP DNA sequencing
kit.
Mutagenesis--
To construct the cDNAs coding the mutant
hETB receptors by cassette mutagenesis (27), we used SR Research,
Howard
Hughes Medical Institute and the Department of Molecular Genetics,
University of Texas Southwestern Medical Center,
Dallas, Texas 75235-9050
ABSTRACT
Top
Abstract
Introduction
Procedures
Results
Discussion
References
INTRODUCTION
Top
Abstract
Introduction
Procedures
Results
Discussion
References
ET-2
ET-3. ETB accepts
all three isopeptides equally. These receptors regulate multiple
effector pathways, for example, phospholipase C via Gq, and
adenylyl cyclase via Gs in smooth muscle cells
(ETA), and via Gi in endothelial cells (ETB) (12, 13). Mice with targeted null disruption of
either Ednrb or Edn3 exhibit an identical
phenotype, coat color spotting, and aganglionic megacolon, similar to
HSCR or Shah-Waardenburg syndrome in humans (14, 15). Some naturally
occurring HSCRs, in humans (a large, inbred Mennonite kindred), mice
(piebald-lethal and lethal spotting), or rats (spotting lethal), are
related with mutations in EDNRB or EDN3 (14-18).
In isolated patients of HSCR, different mutations of EDNRB
or EDN3 have also been reported (19-24), but no functional
analyses of the mutant receptors have so far been performed. To
investigate whether mutations in EDNRB are related with HSCR
in non-inbred populations in Japan, we examined alterations of the gene
in 31 patients and analyzed functional properties of the mutant
ETB receptors.
EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results
Discussion
References
promoter-based mammalian expression vector pME18Sf
, which carried a
cDNA construct encoding the wild-type hETB receptor
(28) (kindly provided by Dr. A. Sakamoto, The Institute of Physical and
Chemical Research, Saitama, Japan). Mutagenic oligodeoxynucleotide
cassettes were created by recombinant PCR with primers (see Fig.
1) (29). The plasmids containing the
cDNAs encoding the wild-type hETB receptor and the
mutated cassette fragments were treated with the unique cognate restriction enzymes and then ligated (Fig. 1). The mutant plasmids were
identified by restriction analysis and verified by automated DNA
sequencing.
View larger version (9K):
[in a new window]
Fig. 1.
A diagram of a part of
pME18Sf-/hETB showing amplification primers and restriction
enzymes used. Their sequences were as follows (5'-3'). Replaced
nucleotides are underlined. 1, TCAAAGAACTGCTCCTCAGTG;
2, AGGACACAACCGTGATGATGTATTTGAAAG; 3,
CACGAACACAAGGCGGGACACAACCGTGTT; 4,
CTTTCAAATACATCATCACGGTTGTGTCCT; 5,
AACACGGTTGTGTCCCGCCTTGTGTTCGTG; 6,
AGAAGCAACAGCTCGATATCTGT; 7, CTGAGTATTGACAGATATCGA;
8, TAATGCAGGAATTCAGTGAAG; 9,
CTGAATTCCTGCATTAACCCAATTGCTCTGTATTTGGTGAGAAAAAGATTC;
10, GCTCATAAAATGTCATATGTAGC.
Transient Expression of the Wild-type and the Mutant
hETB Receptors--
CHO and Ltk cells were
maintained in minimum essential medium
and minimum essential medium
supplemented with 10% fetal bovine serum, respectively. The cDNAs
of the wild-type and the mutant hETB receptors were
transfected into CHO or Ltk
cells in 24-well plates using
LipofectAMINE. At 48-72 h after transfection, the cells were used for
the binding assay.
Stable Expression of the Wild-type and the Mutant hETB Receptors-- Each expression plasmid was cotransfected with pSV2neo plasmid into CHO cells as described above. Clonal cell lines resistant to Geneticin (0.5 mg/ml) were isolated by colony lifting and screened for the presence of specific 125I-ET-1 binding.
Membrane Preparation-- The cells were scraped in buffer A (50 mM Tris (pH 7.5), 3 mM EDTA, 1 mM EGTA, 3 mM MgCl2, 50 µM (p-amidinophenyl)methanesulfonyl fluoride, 5 µM pepstatin A, 1 µM bestatin, 10 µM leupeptin) and homogenized by a Potter-Elvehjem homogenizer. The homogenate was centrifuged for 1 h at 4 °C at 100,000 × g for Western blot analysis or at 20,000 × g for membrane binding experiments.
Radioligand Binding Experiment--
125I-ET-1 was
prepared as described before (30). For the competitive binding
experiments, the CHO cells transiently expressing each receptor in
24-well plates were incubated at 4 °C for 3 h in buffer B
(minimum essential medium containing 10 mM Hepes (pH
7.4) and 0.1% bovine serum albumin) containing 100 pM
125I-ET-1 with various concentrations of unlabeled ET-1 or
ET-3. The cells were then transferred in 0.4 M NaOH to a
gamma counter. The density of the receptors was determined by
saturation isotherms of 125I-ET-1 binding to the intact
cells as described above, except a condition of incubation at 4 °C
for 7 h. In membrane binding experiments, to separate bound from
free ligands, membrane pellets were washed and centrifuged at
21,800 × g for 5 min three times. Nonspecific binding
was defined as the binding in the presence of 100 nM
unlabeled ET-1.
Measurement of Intracellular Ca2+ Transient-- The cells were incubated in the loading buffer (20 mM Hepes-Hanks (pH 7.4) containing 11 mM glucose and 0.1% bovine serum albumin) with 4 µM Fura-2/AM for 60 min at 20 °C. Intracellular Ca2+ transients evoked by ET-1 and ET-3 were monitored by a CAF-110 fluorescence spectrophotometer (JASCO Co., Tokyo, Japan) with dual excitation at 340 nm/380 nm and emission at 500 nm.
cAMP Accumulation Assay-- The cells at 80% confluency were incubated in 300 µl of buffer B containing 1 mM 3-isobutyl-1-methylxanthine at 37 °C for 20 min. Agonists and 1 µM forskolin were added, and the cAMP accumulation was allowed to continue for 10 min at 37 °C. The cAMP contents were measured using a Yamasa radioimmunoassay kit.
Northern Blot Analysis--
Total RNA was extracted from the
cells using Trizol. The total RNAs (20 µg) were electrophoresed on a
1% denaturing agarose gel (containing 18% formaldehyde) and blotted
to a nylon membrane. The blots were probed with a 536-bp
(EcoRV-EcoRI restriction) nick-translated
hETB receptor cDNA fragment and subjected to
autoradiography at 80 °C for 34 h. The intensities of
specific mRNAs were quantified using a BAS 2000 Fuji Bio-Image
analyzer (Fuji Photo Film Co., Kawasaki, Japan).
Preparation of the Anti-peptide Antibody Specific for the hETB Receptor-- A peptide (CLKFKANDHGYDNFRSSNKYSSS) corresponding to the carboxyl terminus (420-442) of the hETB receptor was coupled to keyhole limpet hemocyanin. The antiserum was raised in Japanese White rabbits (2.5 kg). The peptide keyhole limpet hemocyanin was emulsified with Freund's complete adjuvant and injected subcutaneously at multiple sites on the back five times biweekly. The serum was affinity purified with Sulfolink Coupling Gel (Pierce) coupled with the peptide. The antibody recognized only the ETB receptor and not the ETA receptor. The details will be published elsewhere.2
Immunostaining-- The cells were fixed for 1 h in PBS containing 4% paraformaldehyde and then immersed in 50% ethanol in PBS for 10 min. After blocking for 1 h with 10% goat serum in PBS, the cells were incubated with 4 µg/ml anti-hETB receptor antibody for 12 h at 4 °C. After washing, the cells were incubated in PBS containing 1% goat serum and the fluorescein isothiocyanate-conjugated goat anti-rabbit F(ab')2 fragments for 3 h at room temperature. Fluorescence images were taken in a confocal microscope (Zeiss LSM; Carl Zeiss, Thornwood, NY) using a × 63 objective lens.
Western Blot Analysis and Low Temperature SDS-PAGE-- The membrane samples were separated by SDS-PAGE, electroblotted to a polyvinylidene difluoride membrane, and blocked with 4% skim milk for 12 h. After washing, the membrane was incubated with 4 µg/ml anti-hETB receptor antibody for 4 h at room temperature and followed by incubation with 0.3 µg/ml peroxidase-conjugated goat anti-rabbit IgG for 1 h. The bands were visualized by the Western blot chemiluminescence reagent and quantified using the NIH Image program. The low temperature SDS-PAGE was performed as described (31). Briefly, the membrane protein samples (20 µg) were incubated at 4 °C for 3 h in buffer B containing 100 pM 125I-ET-1 with or without 100 nM unlabeled ET-1. After washing, the samples were subjected to SDS-PAGE at 4 °C and to autoradiography for 35 h.
![]() |
RESULTS |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
SSCP and DNA Sequence Analyses-- We analyzed alterations of EDNRB in 31 patients with HSCR (Table I); the ratio of males is 74% (23:31), and those of short type and familial HSCR are 71% (15:21, length undetermined in 10 cases) and 6% (2:31), respectively. In SSCP analyses of the seven exons containing the entire coding region of EDNRB, we identified three mobility shifts, two in exon 1, and one in exon 6 (Fig. 2A). The allelic status of patients 19, 20, and 16 were heterozygous with normal and aberrant bands, homozygous consisting of aberrant bands and heterozygous with normal and aberrant bands, respectively. Nucleotide sequence analysis showed two transversions, A to T at nucleotide 311 and C to A at nucleotide 1170, and a transition, T to C at nucleotide 325 (Fig. 2B). All mutations were missense; the first transversion resulted in the substitution of isoleucine for asparagine at position 104 (N104I), the second, arginine for serine at position 390 (S390R), and the transition, arginine for cysteine at position 109 (C109R). N104I and C109R mutations are located within the transmembrane domain (TM) 1, and S390R is located in the carboxyl-terminal region and adjacent to TM 7.
|
|
Ligand Affinity of the Wild-type or the Mutant hETB
Receptors--
To clarify whether these mutations were related with
HSCR predisposition, we examined binding affinities for ET-1 and ET-3 by the competitive binding experiments using intact CHO cells transiently expressing the mutant hETB receptors. The
IC50 values of the wild-type, N104I, and S390R receptors
were as follows: 147 ± 39, 240 ± 81, and 159 ± 22 pM for ET-1; 492 ± 120, 339 ± 143, and 328 ± 135 pM for ET-3, respectively (Table
II). Similar IC50 values were
obtained in the stably expressing cells (data not shown). These results
indicated that N104I and S390R receptors have the ligand affinities
closely similar to those of the wild type. In contrast, CHO or
Ltk cells transfected with C109R receptors showed almost
no specific 125I-ET-1 binding at 100 pM.
|
Ligand-induced Intracellular Ca2+ Transient and Inhibition of Adenylyl Cyclase Activity via the Wild-type or the Mutant hETB Receptors-- To analyze functional properties of the mutant receptors, we used CHO clonal cell lines stably expressing the wild-type (CHOW), N104I (CHON104I), and S390R (CHOS390R) receptors whose densities were 8.6, 3.8, and 33.3 fmol/105 cells, respectively (Table II). In CHOW and CHON104I, ET-1 elicited similar concentration-dependent increases in [Ca2+]i transients (Fig. 3A, Table II). In contrast, the [Ca2+]i responses in CHOS390R were markedly decreased, despite the fact that the receptor density was higher than that of CHOW. The EC50 values of CHOW and CHOS390R were 146 ± 74 and 4,639 ± 1,468 pM, and their maximal responses (Emax) were 157.6 ± 4.5 and 15.8 ± 2.3%, respectively.
|
Properties of C109R Receptors-- During the course of screening for colonies stably expressing C109R receptors, none of the colonies showed specific 125I-ET-1 binding at 100 pM, as observed in the cells transiently expressing C109R receptors. To test a possibility that this phenomenon was due to the low levels of the mRNA, a CHO cell line stably expressing C109R receptors (CHOC109R) was selected, and the amounts of the mRNA and the receptor proteins in the plasma membrane in CHOC109R were examined by Northern blotting and binding analyses. The mRNA level in CHOC109R was proven to be about seven times higher than that in CHOW. In the intact CHOW and CHOC109R cells, the Bmax values were 3.48 and 0.15 fmol/105 cells, and the Kd values were 0.17 and 0.96 nM, respectively (Fig. 4). On the other hand, in CHOC109R membrane preparations, the displacement analysis of 125I-ET-1 bindings at 1 nM by unlabeled ET-1 revealed the surprisingly low affinity (the IC50 value was 39.5 ± 19.8 nM), in no agreement with the case of the intact cells.
|
Immunostaining with the Anti-hETB Receptor Antibody of the Wild-type and the C109R Cells-- To obtain further evidence that the mRNAs were actually translated, the CHO cells were subjected to immunostaining with the anti-hETB receptor antibody. In CHOW, the translated hETB receptors existed diffusely in the entire cells, especially densely in cell processes (Fig. 5A). On the other hand, in CHOC109R, only the regions near the nuclei were stained (Fig. 5B). These stainings were not observed in mock-transfected CHO cells (Fig. 5C). Western blot analysis showed two major bands of 50 and 33 kDa, and a minor band of 44 kDa in CHOW. In contrast, in CHOC109R, one major band of 44 kDa and a faint band of 50 kDa were detected (Fig. 5D). The relative amounts of the 44-kDa protein were 15.3% in CHOW and 80.1% in CHOC109R. Therefore, the 44-kDa protein might account for the staining nearby the nuclei in CHOC109R. These bands were all absent in mock-transfected cells.
|
![]() |
DISCUSSION |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
In this study, we analyzed alterations of EDNRB in 31 patients with HSCR and detected three novel mutations: two transversions, A to T and C to A, at nucleotide 311 (N104I) and 1170 (S390R), respectively, and a transition, T to C, at nucleotide 325 (C109R). ETB is a heptahelical receptor that equally binds all three endothelin isopeptides and is involved in the intracellular signaling pathway via heterotrimeric G proteins (17, 18). The analyses of both intracellular Ca2+ transients and adenylyl cyclase activities of these mutants revealed that S390R mutation significantly decreased the responses to ET-1, although the binding affinities to the ligands were as high as the wild type. C109R receptors exhibited almost no binding to ET-1 and no functional activities due to the lack of the functionally active receptors in the plasma membrane, because the mutant receptors localized mainly around the nuclei. On the other hands, N104I receptors showed almost the same characteristics as those of the wild type. Taken together, it is concluded that S390R mutation causes a disorder of the intracellular signaling after the binding with agonists, that C109R mutation impairs the translocation of the receptor proteins to the plasma membrane, and that N104I mutation seems polymorphous.
The newly found mutations of EDNRB in this report account
for about 6% (2:31) of HSCR, consistent with the previous report (11).
Their inheritance states and phenotypes were as follows: one was
heterozygous and long segment HSCR, and the other was homozygous and
short segment HSCR. Both patients had no associated disease. As
described in previous reports (19, 25-27), these situations are in
agreement with a hypothesis that HSCR would be a multigenic disorder.
Namely an EDNRB mutation is neither necessary nor sufficient
for explaining all clinical HSCR cases but, at least, it possibly
accounts for some of them. It is well established that the disruption
of the genes encoding the Ret or ETB receptor causes HSCR.
Consequently, it is reasonable to expect that mutations of the genes of
molecules essential for the signaling pathways via these receptors,
such as GDNF, GDNF receptor- (32), neurturin, neurturin receptor-
(33, 34), ET-3, and ECE, might lead to HSCR. In fact, mutations in
EDN3 caused HSCR (28, 29). However, a mutation in
GDNF itself was neither necessary nor sufficient to cause
HSCR (35, 36), because major defects in the Ret pathway would be
embryonic lethal or roles of GDNF in enteric neurogenesis could be
compensated for by other neurotrophic factors, for example, neurturin.
The analysis of another HSCR model mouse, the Dominant megacolon (Dom),
might introduce a novel susceptibility gene that lies in human
chromosome 22q12-q13 (37).
In this report, we performed functional analyses of the mutant hETB receptors. S390R mutation prevented the mutant receptors from coupling with heterotrimeric G proteins, resulting in decreases in the functions. The amino-terminal segment of the cytoplasmic domain from amino acid residues 390-402 contains the putative palmitoylation site and forms a fourth cytoplasmic loop, as found in other G protein-coupled receptors including the ETA receptor (38). This loop in the ETA receptor is required to couple with Gq but not Gs. In coupling of the ETA receptor with Gq, this requirement is also revealed (39). The S390R mutation found in the present study, the replacement of serine 390 with arginine, a positively charged amino acid residue, might cause conformational change of this fourth cytoplasmic loop and might decrease in coupling with G proteins.
C109R mutation that occurred in the amino-terminal region of TM 1 impaired the translocation of the mutant hETB receptor into the plasma membrane. Why C109R receptors are not transported into the
plasma membrane with their proper orientation? It is generally accepted
that when integral membrane proteins are inserted into the endoplasmic
reticulum membrane, about 20 amino acids of the amino-terminal region
would play a role as a signal sequence and lead the translated
polypeptide into the luminal space of the endoplasmic reticulum. It is
also known that TM 1 would play a topogenic role as a stop transfer
sequence (40, 41) and that these segments would require sufficient
hydrophobicity to act efficiently. For example, when the non-polar
amino acid residue in the type 1 signal anchor sequence of cytochrome
P450 was replaced with the basic amino acid residue, the signal anchor
sequence was converted to the secretory signal sequence (42). In the case of C109R mutation in this study, the replacement of cysteine with
arginine in TM 1 might change the targeting function of TM 1 both by
the positively charged group and by the shortened length of the
hydrophobic stretch of TM 1. Thus it seems possible that this mutant
receptor might deviate from the normal transport pathway from the
endoplasmic reticulum to the plasma membrane because of the improper
folding and/or membrane topology, resulting in the accumulation near
the nuclei (Fig. 5B). A similar example of the hamster
-adrenergic receptor was reported previously (43).
It is well known that the normal processing of the wild-type receptors generates a 50-kDa protein and its further degraded form, a 33-kDa protein, by metal proteinases (44). In addition to the wrong translocation as described above, Western blot analysis showed that C109R receptor was processed to an unusual 44-kDa protein and a 50-kDa protein, as a major and a minor products, respectively. In the present study, this 44-kDa protein was also observed in the wild type, although it was a minor component. The binding studies revealed C109R receptors to have the very low Bmax and the fairly high affinity in the surface of intact cells but the surprisingly low affinity in the total membrane preparations, which include plasma membranes and subcellular organellar membranes (Fig. 4C). Together with the relative ratios of the 44- and 50-kDa proteins in CHOW and CHOC109R cells, these results strongly indicate that the 50-kDa protein, which is located in the plasma membrane as a major form in CHOW and as a minor component in CHOC109R, has the high affinity and that the 44-kDa protein, which is located near the nuclei as a major component in CHOC109R and as a minor component in CHOW, has the very low affinity.
In this study, we identified two mutations in EDNRB susceptible to HSCR and demonstrated that the functional defects of the mutant receptors could be due to not only the impairment of signaling pathways but also the unusual processing pathway and the wrong translocation.
![]() |
FOOTNOTES |
---|
* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Present address: The Howard Hughes Medical Institute and the Dept.
of Molecular Genetics, University of Texas Southwestern Medical Center,
Dallas, TX 75235-9050.
§§ To whom correspondence and reprint requests should be addressed: the Division of Cardiovascular Biology, Center for Biomedical Science, Chiba University School of Medicine, 1-8-1, Inohana, Chuo-ku, Chiba 260-0856, Japan. Tel.: 81-43-226-2194; Fax: 81-43-226-2196; E-mail: kimura{at}med.m.chiba-u.ac.jp.
1
The abbreviations used are: HSCR,
Hirschsprung's disease; ET, endothelin; ETA receptor,
endothelin A receptor; hETB receptor, human endothelin B
receptor; G protein, guanine nucleotide-binding protein; CHO, Chinese
hamster ovary; Ltk, thymidine kinase defective L; SSCP,
single strand conformation polymorphism; PBS, phosphate-buffered
saline; GDNF, glial cell line-derived neurotrophic factor; bp, base
pair(s); TM, transmembrane domain; PAGE, polyacrylamide gel
electrophoresis; PCR, polymerase chain reaction.
2 M. Takimoto and S. Hori, manuscript in preparation.
![]() |
REFERENCES |
---|
![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|